Clinuvel Pharmaceuticals (ADR) (CUVL)
Commercializes SCENESSE® for adult EPP and develops melanocortin therapies.
$5.80
After hours+0.02 (+0.35%)
At close$5.78(−0.34%)
No news on record for this listing yet.
Commercializes SCENESSE® for adult EPP and develops melanocortin therapies.
No news on record for this listing yet.